FDA found no clinical study testing Epitalon in patients with insomnia and no evidence supporting the proposed subcutaneous route
Orders before 2 PM PT ship same day (Mon Fri)
Liposomal BPC-157 + TB-500 is designed to support recovery at a deeper level
The compound's effects are mechanistically downstream from its presenceit initiates biological processes that continue autonomously after plasma clearance
The FDA added it to injectable semaglutide in January 2025, and it climbs the dose axis like everything else. Burning or tingling skin tracks the dose, not the weight lost, and an active-comparator study put the risk about twice that of another weight-loss drug. The mechanism is unsettled: the tempting "it is the drugs signaling arm" story is ruled out, because the strongest GLP-1 signaler in the class carries no such signal
Found primarily in the brain, it easily crosses the blood-brain barrier and has been used to address sleep issues, chronic pain, stress-related symptoms, and low testosterone by stimulating luteinizing hormone (LH)